Total Payments
$4,428
2024 Payments
$455.18
Companies
22
Transactions
50
Medicare Patients
1,701
Medicare Billing
$281,030
Payment Breakdown by Category
Other$3,018 (68.1%)
Food & Beverage$915.47 (20.7%)
Consulting$495.00 (11.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $2,640 | 1 | 59.6% |
| Food and Beverage | $915.47 | 42 | 20.7% |
| Consulting Fee | $495.00 | 4 | 11.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $378.00 | 3 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aurinia Pharma U.S., Inc. | $2,860 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $270.00 | 3 | $0 (2023) |
| Travere Therapeutics, Inc. | $245.54 | 2 | $0 (2024) |
| Vifor Pharma, Inc. | $220.31 | 2 | $0 (2021) |
| Relypsa, Inc. | $131.89 | 8 | $0 (2019) |
| GENZYME CORPORATION | $125.00 | 1 | $0 (2018) |
| Mallinckrodt Enterprises LLC | $115.91 | 5 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $74.34 | 5 | $0 (2017) |
| ANI Pharmaceuticals, Inc. | $59.57 | 2 | $0 (2024) |
| Becton, Dickinson and Company | $53.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $455.18 | 11 | Travere Therapeutics, Inc. ($225.00) |
| 2023 | $269.07 | 7 | GlaxoSmithKline, LLC. ($180.00) |
| 2022 | $2,915 | 4 | Aurinia Pharma U.S., Inc. ($2,825) |
| 2021 | $220.31 | 2 | Vifor Pharma, Inc. ($220.31) |
| 2019 | $159.95 | 9 | Relypsa, Inc. ($51.73) |
| 2018 | $198.37 | 5 | GENZYME CORPORATION ($125.00) |
| 2017 | $210.24 | 12 | Merck Sharp & Dohme Corporation ($74.34) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Becton, Dickinson and Company | Site-Rite (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $53.00 | General |
| Category: Catheter Care and Medication Delivery | ||||||
| 11/06/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Catheter Lock Solution | ||||||
| 11/01/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/01/2024 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $225.00 | General |
| 09/25/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Catheter Lock Solution | ||||||
| 09/17/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/06/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/04/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Catheter Lock Solution | ||||||
| 08/27/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: TRANSPLANTATION | ||||||
| 06/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: DIABETES | ||||||
| 05/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardio-renal | ||||||
| 11/30/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Diabetes | ||||||
| 10/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $90.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/22/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $90.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.54 | General |
| 01/06/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/18/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/04/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Honoraria | Cash or cash equivalent | $2,640.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/01/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $157.22 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/18/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $90.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Hyperkalemia | ||||||
| 01/04/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: Hyperkalemia | ||||||
| 12/20/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 301 | 482 | $121,523 | $33,735 |
| 2022 | 7 | 392 | 715 | $241,452 | $67,191 |
| 2021 | 9 | 460 | 806 | $305,497 | $87,555 |
| 2020 | 9 | 548 | 1,035 | $303,649 | $92,549 |
Total Patients
1,701
Total Services
3,038
Medicare Billing
$281,030
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 71 | 106 | $29,450 | $7,819 | 26.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 103 | $20,497 | $6,291 | 30.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 39 | $21,606 | $5,351 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 88 | 108 | $20,292 | $5,233 | 25.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 50 | $14,250 | $4,685 | 32.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 36 | 76 | $15,428 | $4,356 | 28.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 13 | 85 | $84,660 | $24,790 | 29.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 71 | 207 | $41,193 | $11,814 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 104 | 152 | $42,268 | $10,401 | 24.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 49 | 55 | $20,735 | $6,039 | 29.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 30 | 53 | $15,105 | $4,233 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 72 | 83 | $15,596 | $4,168 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 31 | $11,036 | $2,791 | 25.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 20 | 30 | $6,090 | $1,765 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 19 | $4,769 | $1,191 | 25.0% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 19 | 107 | $105,825 | $31,342 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 127 | 173 | $50,074 | $13,343 | 26.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 81 | 185 | $36,543 | $10,750 | 29.4% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 14 | 31 | $25,383 | $7,527 | 29.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 56 | 62 | $23,113 | $6,514 | 28.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 54 | $19,042 | $5,151 | 27.1% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 42 | 73 | $14,657 | $4,269 | 29.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 47 | $13,035 | $3,859 | 29.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 44 | 45 | $8,412 | $2,279 | 27.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 16 | 16 | $6,186 | $1,629 | 26.3% |
About Dr. Arnold Alper, M.D
Dr. Arnold Alper, M.D is a Nephrology healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477509107.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arnold Alper, M.D has received a total of $4,428 in payments from pharmaceutical and medical device companies, with $455.18 received in 2024. These payments were reported across 50 transactions from 22 companies. The most common payment nature is "Honoraria" ($2,640).
As a Medicare-enrolled provider, Alper has provided services to 1,701 Medicare beneficiaries, totaling 3,038 services with total Medicare billing of $281,030. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Specialist
- Location New Orleans, LA
- Active Since 05/25/2006
- Last Updated 04/05/2017
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1477509107
Products in Payments
- LUPKYNIS (Drug) $2,860
- Veltassa (Drug) $352.20
- BENLYSTA (Biological) $270.00
- ACTHAR (Biological) $132.54
- THYMOGLOBULIN (Drug) $125.00
- ZEPATIER (Drug) $74.34
- PURIFIED CORTROPHIN GEL (Drug) $59.57
- Site-Rite (Device) $53.00
- DefenCath (Drug) $48.23
- ENVARSUS (Drug) $23.96
- AURYXIA (Drug) $20.31
- LOKELMA (Drug) $18.24
- Velphoro (Drug) $17.91
- SAMSCA (Drug) $17.76
- GATTEX (Drug) $16.81
- JARDIANCE (Drug) $16.48
- SOLIRIS (Drug) $15.86
- Kerendia (Drug) $15.57
- FARXIGA (Drug) $15.39
- Ozempic (Drug) $14.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in New Orleans
Juan Carlos Velez, Md, MD
Nephrology — Payments: $295,232
Nephrology $295,232
Dr. Myra Kleinpeter, Md, MD
Nephrology — Payments: $61,216
Nephrology $61,216
Michael Touchy, M.d, M.D
Nephrology — Payments: $21,162
Nephrology $21,162
Farshid Yazdi, M.d., M.s.p.h, M.D., M.S.P.H
Nephrology — Payments: $16,340
Nephrology $16,340
Eduardo Rodriguez, M.d, M.D
Nephrology — Payments: $10,344
Nephrology $10,344
Juan Medaura, Md, MD
Nephrology — Payments: $7,820
Nephrology $7,820